Projected Growth of the Global Artificial Intelligence (AI) In Biopharmaceuticals Market to Reach $24.63 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in biopharmaceuticals market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Artificial Intelligence (AI) In Biopharmaceuticals Market By The End Of 2029?

The prostate cancer drugs market has experienced robust expansion over recent years. Projections indicate it will grow from $18.53 billion in 2024 to $19.51 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.3%. The historic increase in market size is attributable to an aging population, increased diagnoses, significant drug innovation, enhanced awareness and education initiatives, and improvements in reimbursement and insurance coverage.

The prostate cancer drugs market size is projected to experience substantial expansion in the coming years. It is anticipated to grow to “$24.63 billion in 2029, achieving a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is primarily attributed to the rising incidence of prostate cancer, the emergence of new markets, supportive government policies, and increased research and development investments. Key trends in the forecast period include precision medicine, the development of immunotherapy and targeted therapies, personalized medicine approaches, advancements in clinical trials and the drug pipeline, the application of combination therapies, biomarker-driven treatments, and the adoption of telemedicine and remote monitoring.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2592&type=smp

Which Business Drivers Are Underpinning The Growth Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The increasing elderly male population acts as a significant catalyst for the prostate cancer drugs market. Prostate cancer stands as one of the most widespread cancer types among men over 60. According to ACL (Administration For Community Living), a US-based government organization, the geriatric population is projected to grow by 21.6% by 2040. Within this demographic, men are more commonly affected by prostate cancer than women. For example, in January 2022, the American Cancer Society, a US-based organization, stated that prostate cancer typically develops in older men and non-hispanicblack men, with roughly 6 out of 10 cases diagnosed in men aged 65 or older (the geriatric population). Therefore, the rising geriatric male population actively drives the expansion of the prostate cancer market.

What Are The Principal Segment Types In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The prostate cancer drugs market covered in this report is segmented –

1) By Type: Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer

2) By Therapy: Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy

3) By End User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Hormone Sensitive Prostate Cancer: Early-Stage Prostate Cancer, Locally Advanced Prostate Cancer, Metastatic Prostate Cancer

2) By Hormone Refractory Prostate Cancer: Castration-Resistant Prostate Cancer (CRPC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)

How Are Industry Trends Steering The Expansion Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The market is observing an emerging trend in the application of combination therapy for treating prostate cancer. This development is primarily driven by the ineffectiveness of monotherapy for certain prostate cancer patients. Consequently, companies operating in the prostate cancer drugs market are increasing their investments in combination therapy approaches for prostate cancer treatment. For instance, Pfizer shared findings from its Phase 3 PROSPER trial, involving patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC). These results indicated that combining XTANDI (enzalutamide) with androgen deprivation therapy (ADT) led to a substantial 71% reduction in the likelihood of developing metastases or death, as opposed to using ADT exclusively. Likewise, other combined treatment strategies, such as radiation therapy paired with androgen deprivation therapy for recurrent prostate cancer in men, and the administration of the chemotherapy drug docetaxel (Taxotere) alongside ADT, are also employed in managing prostate cancer.

Which Companies Are Contributing Significantly To The Artificial Intelligence (AI) In Biopharmaceuticals Market Growth?

Major companies operating in the prostate cancer drugs market include Astellas Pharma Inc., AstraZeneca PLC, Johnson & Johnson, Sanofi S.A., Bayer AG, F. Hoffmann-La Roche AG, Abbott Laboratories, Pfizer Inc., Novartis International AG, F. Hoffmann-La Roche Ltd., Tolmar Inc., AbbVie Inc., Siemens Healthineers AG, Genomic Health Inc., OPKO Health Inc., Siemens Healthcare GmbH, MDxHealth SA, Myriad Genetics Inc., Janssen Biotech Inc., Clovis Oncology Inc., Merck Sharp & Dohme Corp., Dendreon Corporation, Ferring Pharmaceuticals Inc., GlaxoSmithKline plc, Ipsen Biopharmaceuticals Inc., Merck & Co. Inc., Eli Lilly and Company Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novartis AG, Amgen Inc., Biogen Inc., Celgene Corporation, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Agios Pharmaceuticals Inc., Exelixis Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

Which Region Offers The Most Opportunity For Artificial Intelligence (AI) In Biopharmaceuticals Market Expansion?

North America was the largest region in the prostate cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the prostate cancer drugs market during the forecast period. The regions covered in the prostate cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2592&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company

Diuretics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795